Periodic limb movement disorder

disease
On this page

Summary

Periodic limb movement disorder (MONDO:0005905) is a disease with 5 GWAS associations across 3 studies and 3 clinical trials. A subtype of sleep-wake disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • GWAS associations: 5
  • Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameperiodic limb movement disorder
Mondo IDMONDO:0005905
EFOEFO:0007428
DOIDDOID:9207
ICD-10-CMG47.61
ICD-111846518306
SNOMED CT418763003
UMLSC0751774
MedGen199731
Is cancer (heuristic)no

Data availability: 5 GWAS associations (3 studies).

Disease family

This is a subtype of sleep-wake disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › sleep disordersleep-wake disorderperiodic limb movement disorder

Related subtypes (11): bruxism, recurrent hypersomnia, sleep apnea syndrome, hypersomnia, REM sleep behavior disorder, autosomal dominant cerebellar ataxia, deafness and narcolepsy, hereditary sensory neuropathy-deafness-dementia syndrome, autoimmune encephalopathy with parasomnia and obstructive sleep apnea, narcolepsy, circadian rhythm sleep disorder, sleep disorder, initiating and maintaining sleep

Genetics & variants

GWAS landscape

5 GWAS associations across 3 studies. Top hits map to 2 distinct genes (as reported by GWAS).

Top associations by p-value

rsIDp-valueGeneRisk alleleOdds ratio
rs93690623e-22BTBD9?0.21
rs1138515544e-12MEIS1T1.63
rs42360604e-11BTBD9?0.58
rs5283963473e-08HCN1 - EMB?

Top studies (by case count)

StudyLead authorYearCasesControlsTitle
GCST90651593Liu TY2025115203,812Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population.
GCST90270120Edelson JL202200The Genetic Etiology of Periodic Leg Movement in Sleep.
GCST90270121Edelson JL202200The Genetic Etiology of Periodic Leg Movement in Sleep.

Variant details and genetic-evidence tiers

Tier distribution (top 50 variants)

TierVariants
Tier 1: coding0
Tier 2: splice/UTR0
Tier 3: regulatory0
Tier 4: intronic/intergenic4

MAF distribution

BucketVariants
common (>=0.05)3
low_freq (0.01-0.05)0
rare (<0.01)0
unknown1

Functional consequences

ConsequenceCount
intron_variant3
intergenic_variant1

Top variants

rsIDChrPosAllelesMAFConsequenceGenep-valueTier
rs9369062638469527A>C,G,T0.05intron_variantBTBD93e-22Tier 4: intronic/intergenic
rs113851554266523432G>A,T0.05intron_variantMEIS14e-12Tier 4: intronic/intergenic
rs4236060638502311C>G,T0.05intron_variantBTBD94e-11Tier 4: intronic/intergenic
rs528396347550284400CA>Cintergenic_variantHCN1 - EMB3e-08Tier 4: intronic/intergenic

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified3

Top trials by phase / activity

NCTPhaseStatusTitle
NCT04569643Not specifiedUNKNOWNPeriodic Limb Movement Syndrome in Patients With Cerebral Small Vessel Disease.
NCT04618978Not specifiedCOMPLETEDPeriodic Leg Movements’ Diagnosis in Spinal Cord Injury: Actigraphy as an Alternative for Polysomnography?
NCT04816136Not specifiedCOMPLETEDConsequences of Post Stroke Polysomnographic Abnormalities on Functionnal Recovery and Survival After an Ischemic Stroke

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.